Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain
- PMID: 10029096
- DOI: 10.1097/00005072-199902000-00003
Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain
Abstract
Recently, an N-terminal fragment of huntingtin was localized to neuronal intranuclear inclusions (NII), presumed to cause cellular dysfunction, and to inclusions in dystrophic neurites (IDN) in the neostriatum and neocortex of Huntington disease (HD) patients. In the present immunohistochemical study of autopsy brain of 2 juvenile-onset HD patients, 5 HD patients with adult-onset, and 5 controls, NII and IDN as stained with both N-terminal antiserum to huntingtin and ubiquitin antiserum were detected in the HD neostriatum, neocortex, and allocortex, but not in the HD pallidum, cerebellum, and substantia nigra nor in control brain. The frequency of NII in the HD neocortex was highest in the juvenile patients. Within the allocortex, NII and IDN were found in the entorhinal region, subiculum, and pyramidal cell layer of Ammon's horn. N-terminal huntingtin antiserum also labeled intranuclear granular structures adjacent to the neuronal nuclear membrane in 5 HD patients, one control with idiopathic epilepsy, and one with Alzheimer disease. Our results show that NII formation in HD involves the allocortex in addition to the neostriatum and neocortex. The development of NII in the neocortex and allocortex in HD brain might contribute to the emergence of the cognitive and behavioral symptoms of the disease.
Similar articles
-
Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.Science. 1997 Sep 26;277(5334):1990-3. doi: 10.1126/science.277.5334.1990. Science. 1997. PMID: 9302293
-
Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease.J Neuropathol Exp Neurol. 1999 Feb;58(2):165-73. doi: 10.1097/00005072-199902000-00006. J Neuropathol Exp Neurol. 1999. PMID: 10029099
-
Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein.Exp Neurol. 1999 Mar;156(1):92-9. doi: 10.1006/exnr.1998.7005. Exp Neurol. 1999. PMID: 10192780
-
The localization and interactions of huntingtin.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1021-7. doi: 10.1098/rstb.1999.0454. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434301 Free PMC article. Review.
-
Juvenile onset Huntington's disease--clinical and research perspectives.Ment Retard Dev Disabil Res Rev. 2001;7(3):153-7. doi: 10.1002/mrdd.1022. Ment Retard Dev Disabil Res Rev. 2001. PMID: 11553930 Review.
Cited by
-
Progression of basal ganglia pathology in heterozygous Q175 knock-in Huntington's disease mice.J Comp Neurol. 2021 May 1;529(7):1327-1371. doi: 10.1002/cne.25023. Epub 2020 Sep 20. J Comp Neurol. 2021. PMID: 32869871 Free PMC article.
-
Neuronal intranuclear and neuropil inclusions for pathological assessment of Huntington's disease.Brain Pathol. 2007 Jan;17(1):31-7. doi: 10.1111/j.1750-3639.2006.00040.x. Brain Pathol. 2007. PMID: 17493035 Free PMC article.
-
Differential susceptibility of striatal, hippocampal and cortical neurons to Caspase-6.Cell Death Differ. 2018 Jul;25(7):1319-1335. doi: 10.1038/s41418-017-0043-x. Epub 2018 Jan 19. Cell Death Differ. 2018. PMID: 29352267 Free PMC article.
-
Non-apoptotic cell death in animal development.Cell Death Differ. 2017 Aug;24(8):1326-1336. doi: 10.1038/cdd.2017.20. Epub 2017 Feb 17. Cell Death Differ. 2017. PMID: 28211869 Free PMC article. Review.
-
Selective Sparing of Striatal Interneurons after Poly (ADP-Ribose) Polymerase 1 Inhibition in the R6/2 Mouse Model of Huntington's Disease.Front Neuroanat. 2017 Aug 2;11:61. doi: 10.3389/fnana.2017.00061. eCollection 2017. Front Neuroanat. 2017. PMID: 28824383 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical